Clinical Trials on Intermediate AMD
Total 412728 results
-
EyePoint Pharmaceuticals, Inc.CompletedPanuveitis | Posterior Uveitis | Intermediate UveitisIndia
-
Johns Hopkins UniversityMacuSight, Inc.CompletedPanuveitis | Uveitis | Posterior Uveitis | Intermediate UveitisUnited States
-
Weizmann Institute of ScienceHadassah Medical OrganizationRecruitingDietary Fibers | Intermediate FastingIsrael
-
Priovant Therapeutics, Inc.Active, not recruitingNon-infectious Intermediate Uveitis | Non-infectious Posterior Uveitis | Non-infectious Pan UveitisUnited States
-
Duke UniversityCompletedPosterior Uveitis | Intermediate UveitisUnited States
-
AllerganCompletedPosterior Uveitis | Intermediate UveitisFrance, United Kingdom, United States, Spain, Poland, India, South Africa, Korea, Republic of, Canada, Czech Republic, Australia, Germany, Israel, Switzerland, Portugal, Austria, Brazil, Greece
-
Salzburger LandesklinikenCompletedIntermediate Cervical Plexus Block for Carotid EndarterectomyAustria
-
Novartis PharmaceuticalsCompletedNon-infectious Intermediate Uveitis | Non-infectious Posterior Uveitis | Non-infectious PanuveitisUnited States, United Kingdom
-
University of NebraskaUnknownPosterior Uveitis | Intermediate Uveitis | Pan-uveitisUnited States
-
Stanford UniversitySanten Inc.WithdrawnPanuveitis | Uveitis | Posterior Uveitis | Intermediate UveitisUnited States
-
CHU de Quebec-Universite LavalCompletedIntermediate Uveitis | Anterior UveitisCanada
-
AbbVieCompletedNon-infectious Intermediate, Posterior and PanuveitisKorea, Republic of
-
InSightecUnknownLocalized Intermediate Risk Prostate LesionsUnited States
-
St. Franziskus HospitalCompleted
-
University of Sao PauloCompletedTo Study the Influence of an Multifocal Intraocular Lens With Different Addition on Intermediate Visual AcuityBrazil
-
Ohio State University Comprehensive Cancer CenterCompletedIndolent or Intermediate Grade B-cell MalignancyUnited States
-
EyePoint Pharmaceuticals, Inc.TerminatedUveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States
-
Forsight Vision4TerminatedUveitis, Posterior | Uveitis, IntermediateUnited States
-
Clearside Biomedical, Inc.CompletedPanuveitis | Uveitis | Posterior Uveitis | Intermediate Uveitis | Noninfectious UveitisUnited States
-
Tampa Bay Uveitis Center, LLCMallinckrodtCompletedUveitis | Posterior Uveitis | Intermediate Uveitis | Anterior Uveitis | Scleritis | Clinically Significant Macular EdemaUnited States
-
STZ eyetrialNovartis Pharmaceuticals; University Hospital TuebingenCompletedUveitis, IntermediateGermany
-
Massachusetts Eye Research and Surgery InstitutionEli Lilly and CompanyRecruitingUveitis, Anterior | Panuveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States
-
Lux Biosciences, Inc.CompletedPanuveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States, United Kingdom, Canada, Germany, Austria, France, India
-
Brigham and Women's HospitalCompletedKnown CAD, or Intermediate-high Pretest Likelihood for CADUnited States, Canada
-
MallinckrodtTerminatedPanuveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States
-
Smilebiotek Zhuhai LimitedRecruitingIntermediate Age-Related Macular DegenerationChina
-
Ottawa Hospital Research InstituteRecruiting
-
AbbVieActive, not recruitingNon-infectious Intermediate Posterior- or Pan-uveitisChina
-
Can-Fite BioPharmaWithdrawnUveitis, Posterior | Uveitis, IntermediateIsrael
-
Novartis PharmaceuticalsWithdrawnAcute Noninfectious Posterior, Intermediate, or Pan Uveitis
-
Yonsei UniversityTerminatedAcute Coronary Syndrome | Acute Myocardial Infarction | Unstable Angina (Intermediate Coronary Syndrome)Korea, Republic of
-
Clearside Biomedical, Inc.CompletedUveitis, Anterior | Panuveitis | Uveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States
-
Lux Biosciences, Inc.CompletedPanuveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States, United Kingdom, Canada, Germany, Austria, France, India
-
Clearside Biomedical, Inc.CompletedUveitis, Anterior | Panuveitis | Uveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States, India
-
National Eye Institute (NEI)CompletedNon-infectious Intermediate and Posterior UveitisUnited States
-
Peking Union Medical College HospitalUnknownLow/Intermediate Risk-1 MDSChina
-
Notal Vision Ltd.CompletedAMD Population - Intermediate or Advanced AMD | DR Population- With or Without Diabetic Macular EdemaIsrael
-
Dana-Farber Cancer InstituteMedivation, Inc.Completed
-
Henry Ford Health SystemAmerican Cancer Society, Inc.WithdrawnLow or Intermediate Risk Prostate CancerUnited States
-
InSightecCompletedLocalized Low-Intermediate Risk Prostate CancerUnited Kingdom, Israel, Canada, Italy, Singapore
-
Alumis IncActive, not recruitingUveitis, Intermediate | Noninfectious Panuveitis | Uveitis Posterior Non-InfectiousUnited States
-
Notal Vision Inc.CompletedNeovascular Age-related Macular Degeneration | Intermediate Age Related Macular Degeneration (Disorder)United States
-
Shiraz University of Medical SciencesCompletedCombination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermediaβ-Thalassemia IntermediaIran, Islamic Republic of
-
Azienda Socio Sanitaria Territoriale degli Spedali...TakedaUnknownIntermediate Risk Prostate Cancer | High Risk Prostate CancerItaly
-
Association for Innovation and Biomedical Research...European Vision Institute Clinical Research NetworkActive, not recruitingAtrophy | Age Related Macular Degeneration | Prediction | Intermediate AMDPortugal, France, Germany, Ireland, Italy, Netherlands, Spain, Switzerland, United Kingdom
-
Texas Retina AssociatesEye Point PharmaceuticalsRecruitingUveitis, Anterior | Uveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States
-
Ospedale San RaffaeleUniversity of Rome Tor Vergata; University of Genova; Fondazione G.B. Bietti,...RecruitingMacular Degeneration, Dry | Macular Degeneration, Senile | Laser Burn of Retina | Macular Degeneration IntermediateItaly
-
Johns Hopkins UniversityAllerganCompletedUveitis, Posterior | Uveitis, IntermediateUnited States
-
Jan Medical, Inc.CompletedConcussion, IntermediateUnited States
-
Centre Francois BaclesseFrench cancer Institute INCaRecruitingThyroid Cancer | Intermediate RiskFrance